Viewing Study NCT00564720


Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2025-12-26 @ 3:19 AM
Study NCT ID: NCT00564720
Status: TERMINATED
Last Update Posted: 2013-02-15
First Post: 2007-11-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
Sponsor: Hellenic Oncology Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module